We measured the dynamics of B cell subsets, plasma levels of BAFF and CXCL13 before infection and longitudinally during hyperacute HIV-1 infection and determined their influence on the emergence of cross-neutralizing antibodies at approximately 1 year postinfection (PI). The gene discussed is CXCL13; the disease is infection.